Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-097279
Filing Date
2025-07-21
Accepted
2025-07-21 16:41:34
Documents
1
Period of Report
2025-07-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5258
  Complete submission text file 0000950170-25-097279.txt   6679
Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address
Abdun-Nabi Daniel (Reporting) CIK: 0001380187 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37746 | Film No.: 251137702

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Issuer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)